eli lilly mounjaro - Search News

Mounjaro enters India as weight-loss drug

Reuters on MSN · 2d

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with increasing rates of obesity and diabetes.

Markets Insider · 3d

Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover advantage in a market

Bloomberg · 3d

Eli Lilly First to Launch Weight Loss Drug in Obesity-Hit India

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a country that has the world’s third-largest number of obese people.

6hon MSN

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

2d

Eli Lilly Shares Are Up Today: What's Going On?

Eli Lilly & Co. (NYSE: LLY) shares are trading higher Thursday after the company launched its weight-loss drug Mounjaro in ...

2d

Eli Lilly: Growth With Higher Margins

Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...

5d

Eli Lilly wins final approval for $3B expansion in Pleasant Prairie

The vote clears the way for a proposed multibillion-dollar expansion of the former Nexus Pharmaceuticals facility.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results